The Washington-based eHealth Initiative Foundation (eHI) has formed a research program designed to improve drug safety for patients.
The eHI Connecting Communities for Drug Safety Collaboration is a public-private sector effort designed to test new approaches and develop replicable tools for assessing both the risks and the benefits of new drug treatments through the use of health information technology.
Results of the collaborative effort will be placed in the public domain. The project will test and evaluate the value and utility of blinded, anonymized, electronic clinical health information to detect and evaluate drug safety signals.
The collaboration involves New York-based Pfizer Inc., Johnson & Johnson (New Brunswick, N.J.), Indianapolis-based Eli Lilly, Boston-based Partners HealthCare System and the Regenstrief Institute (Indianapolis).